Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
AstraZeneca (AZN)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
OPERATING METRICS
REVENUE SOURCES
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for AZN as compared to
Top Competitors
Drug Manufacturers - Major
Drug Manufacturers
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS (
See all
)
Revenue
►
32.1B
HIGH
R&D Expense
►
5.18B
AVG
R&D/Sales Ratio
►
16.4%
AVG
Total Drug Recalls
►
12.0
HIGH
Number of Drugs in Phase I
►
34.0
AVG
Number of Drugs in Phase II
►
31.0
AVG
Number of Drugs in Phase III
►
10.0
AVG
Revenue
Number of Drug Recalls
New Drug Applications
Number of Drugs in Phase I
Number of Drugs in Phase II
Number of Drugs in Phase III
R&D/Sales Ratio
Research and Development Expense
Net Income
Operating Income
INCOME STATEMENT (
See all
)
Revenue
►
32.1B
HIGH
EBITDA
►
13.9B
AVG
Net Income
►
7.21B
AVG
Revenue Growth
►
1.5%
AVG
Net Income Growth
►
17.9%
AVG
Operating Margin
►
31.9%
AVG
Net Margin
►
22.5%
AVG
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Operating Income
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest vs Continuing Income
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
1.68
HIGH
Current Ratio
►
1.36
LOW
Quick Ratio
►
1.23
LOW
Interest Coverage Ratio
►
9.82
AVG
Book Value Per Share
►
13.3
Cash Per Share
►
5.34
Loading...
STOCK SUMMARY
Open
44.39
Day Range
44.36
-
44.82
52 Week Range
29.96
-
47.61
Volume
1.30M
Avg Volume (3 mo)
1.39M
Shares Outstanding
1.45B
Market Cap
64.9B
VALUATION
Price to Earnings (P/E)
►
9.07
AVG
Price to Book (P/B)
►
3.37
AVG
Price to Sales (P/S)
►
2.04
AVG
Return on Assets (ROA)
►
16.8%
AVG
Return on Equity (ROE)
►
40.6%
AVG
EV/EBITDA
►
6.05
LOW
Dividend Yield
2.6%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Held by institutions
4.4%